Trial Profile
A real world retrospective study to determine the outcomes of treatment with Dimethyl Fumarate within one year after initiation in patients with relapsing remitting Multiple Sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Nov 2016
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 20 Nov 2016 New trial record